Educational level and use of osteoporosis drugs in elderly men and women: a Swedish nationwide register-based study
- 332 Downloads
We examined educational disparities in use of osteoporosis drugs in a nationwide population of Swedes aged 75–89 years old. Individuals with high education were more likely to receive osteoporosis drug treatment than lower educated individuals, particularly among women.
This study aims to investigate whether educational level is associated with use of osteoporosis drugs in the general population of older men and women in Sweden, also after adjustment for fractures.
By record linkage of The Swedish Prescribed Drug Register, The Swedish Patient Register, and The Swedish Education Register, we obtained information on filling of prescriptions for osteoporosis drugs (bisphosphonates, calcium/vitamin D combinations, and selective estrogen receptor modulators) from July to October 2005, osteoporotic fractures from 1998 to 2004, and educational level for 645,429 people aged 75–89 years. Multivariate logistic regression analysis was used to investigate whether education was associated with use of osteoporosis drug therapy.
Higher education was associated with use of osteoporosis drugs for both men [odds ratio (OR)high education vs low, 1.27; 95% confidence interval (CI), 1.19–1.35] and women (ORhigh education vs low, 1.57; 95% CI, 1.52–1.61), after adjustment for age, osteoporotic fractures, and comorbidity (i.e., number of other drugs). Among those who had sustained a fracture (n = 57,613), the educational differences in osteoporosis drug treatment were more pronounced in women than men. Further, women were more likely to receive osteoporosis drug treatment after osteoporotic fracture.
Uptake of osteoporosis drug therapy seems to be unequally distributed in the elderly population, even in a country with presumably equal access to health care.
KeywordsAccess to health care Drug therapy Osteoporosis Pharmacoepidemiology Socioeconomic position
This study was supported by grants from the Swedish Council for Working Life and Social Research (2007–1947) and the Swedish Research Council (2007–5870).
Conflicts of interest
- 11.SBU (The Swedish Council on Technology Assessment in Health Care) (2003) Osteoporosis—prevention, diagnosis and treatment. A sytematic review. SBU, GöteborgGoogle Scholar
- 15.Vanasse A, Dagenais P, Niyonsenga T, Grégoire JP, Courteau J, Hemiari A (2005) Bone mineral density measurement and osteoporosis treatment after a fragility fracture in older adults: regional variation and determinants of use in Quebec. BMC Musculoskelet Disord 6:33. doi: 10.1186/1471-2474-1186-1133 PubMedCrossRefGoogle Scholar
- 18.Wettermark B, Hammar N, MichaelFored C, Leimanis A, Otterblad Olausson P, Bergman U, Persson I, Sundström A, Westerholm B, Rosén M (2007) The new Swedish Prescribed Drug Register—opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf 16:726–735PubMedCrossRefGoogle Scholar
- 20.Statistics Sweden (2004) The Swedish Register of Education. http://www.scb.se/statistik/UF/UF0506/SUN2000English%20version.doc. Accessed 26 Mar 2011.
- 21.WHO Collaborating Centre for Drug Statistics Methodology, Oslo, Norway (2011) http://www.whocc.no/. Accessed 21 Jun 2011
- 22.WHO (2004) ICD-10: International Statistical Classification of Diseases and Related Health Problems: tenth revision, 2nd edn. WHO, GenevaGoogle Scholar
- 24.Haasum Y, Fastbom J, Fratiglioni L, Johnell K (2012) Undertreatment of osteoporosis in persons with dementia? A population-based study. Osteoporos Int 23:1061–1068Google Scholar
- 36.Aging Research Center, Karolinska Institutet, Stockholm University (2007) SWEOLD code book 2002 & 2004. Karolinska Institutet, StockholmGoogle Scholar